SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
(Check One): [x] Form 10-K [ ] Form 11-K [ ] Form 20F [ ] Form 10-Q
[ ] Form N-SAR
For Period Ended: December 31, 2003
[ ] Transition Report on Form 10-K [ ] Transition Report on Form 10-Q
[ ] Transition Report on Form 20-F [ ] Transition Report on Form N-SAR
[ ] Transition Report on Form 11-K
For the Transition Period Ended:__________________________________________
Read attached instruction sheet before preparing form. Please print or
type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above,
identify the item(s) to which the notification relates: ________________________
________________________________________________________________________________
PART I
Registrant Information
Full name of registrant: Altrimega Health Corporation
-----------------------------------------------------
Former name if applicable: N/A
-----------------------------------------------------
Address of principal executive
office (Street and number): 4702 Oleander Drive, Suite 200
-----------------------------------------------------
City, state and zip code: Myrtle Beach, SC 29577
-----------------------------------------------------
Part II
Rule 12b-25 (b) and (c)
If the subject report could not be filed without unreasonable effort or
expense and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box.)
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[X] (b) The subject annual report, semi-annual report, transition report on
Form 10-K, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on
or before the 15th calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion
thereof will be filed on or before the fifth calendar day following the
prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
PART III
Narrative
State below in reasonable detail the reasons why Form 10-K, 11-K,
10-Q, N-SAR or the transition report portion thereof could not be filed within
the prescribed time period. (Attach extra sheets if needed.)
Due to unforeseeable circumstances which caused a delay in preparing
the financial statements for the period ended December 31, 2003, the Registrant
respectfully requests an extension of the filing date of its Annual Report on
Form 10-KSB for the fiscal year ended December 31, 2003.
PART IV
Other Information
1. Name and telephone number of person to contact in regard to this
notification:
John Gandy (843) 497-7028
--------------------------------------------------------------
(Name) (Area code) (Telephone number)
2. Have all other periodic reports required under Section 13 or
15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter period
that the registrant was required to file such report(s) been filed? If the
answer is no, identify report(s).
[ ] Yes [X] No
While the Registrant believes it has filed all of the reports
required under Section 13 or 15(d) of the Securities Exchange Act of 1934, the
Registrant has been advised by the Securities and Exchange Commission that the
Registrant must file amendments to its Form 10-KSB for the fiscal year ended
December 31, 2002, and amendments to its Form 10-QSB for the quarters ended
March 31, 2003, June 30, 2003 and September 30, 2003, and also file a Form 8-K
relating to the combination of the Registrant's accountants with Sellers &
Associates P.C. The Registrant is in the process of preparing these amendments
and Form 8-K.
3. Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or
portion thereof?
[ ] Yes [X] No
If so: attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
Altrimega Health Corporation
(Name of registrant as specified in charter)
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: March 30, 2004 By: /s/ John Gandy
____________________________________
John Gandy, Chief Executive Officer